FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

425189006: Nonacog alfa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2639666018 Nonacog alfa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2643671017 Nonacog alfa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
828511000172114 nonacog alpha fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nonacog alfa (substance) Is a Coagulation factor IX false Inferred relationship Some
Nonacog alfa (substance) Is a Recombinant coagulation factor IX (substance) true Inferred relationship Some
Nonacog alfa (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Enzyme (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Nonacog alfa The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Nonacog alfa (substance) Inferred relationship Some
Product containing only nonacog alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nonacog alfa (substance) Inferred relationship Some 1
Nonacog alfa only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nonacog alfa (substance) Inferred relationship Some 1
Product containing nonacog alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nonacog alfa (substance) Inferred relationship Some 1
Product containing nonacog alfa in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nonacog alfa (substance) Inferred relationship Some 1
Product containing precisely nonacog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Nonacog alfa (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start